Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 74 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Development of a Long-Acting Interleukin-11 Antagonist for the Treatment of Renal Fibrosis
Ningning Pang, Na Zhao, Chunmei An, Keqiang Li, Peiying Li, Naiyuan Wang, Jian Li, Xing Cheng, Nan Zheng,Dong Guo, Xiaochun Xiong
Journal of medicinal chemistryno. 8 (2025): 8429-8438
Cited0Views0WOSBibtex
0
0
Discovery of TBK1Molecular Glue Degraders As a Potential Strategy for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Jing Guo, Haotian Tang, Wenchao Zhao, Yong Li, Shukai Song,Fang Feng, Shengjie Huang, Xuan Wang,Yang Zhou, Junping Pei,Dong Guo,Hua Xie,Xiaoyun Lu
Journal of medicinal chemistry (2025)
Cited0Views0WOSBibtex
0
0
Structure-Based Rational Design and Evaluation of BET-Aurora Kinase Dual-Inhibitors for Treatment of Cancers
Kaikai Lyu, Ying Ren,Jie Mou, Yunfang Yang, Yaoyao Pan,Huijie Zhang,Yanlian Li,Danyan Cao,Lin Chen,Danqi Chen,Dong Guo,Bing Xiong
JOURNAL OF MEDICINAL CHEMISTRYno. 2 (2024): 1344-1364
Cited0Views0WOSBibtex
0
0
Visible-Light-Driven Carboxylative 1,2-Difunctionalization of C=C Bonds with Tetrabutylammonium Oxalate
Sai Wang,Pei Xu, Zhi-Tao Liu, Yi-Qin Liu,Hao-Qiang Jiang, Tian-Zi Hao, Hui-Xian Jiang,Hui Xu,Xu-Dong Cao,Dong Guo,Xu Zhu
ACS central scienceno. 1 (2024): 46-56
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 74

#Citation: 1740

H-Index: 22

G-Index: 41

Sociability: 6

Diversity: 3

Activity: 47

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn